Faculty of Medicine

Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14

Browse

Settings

Subject: search.filters.subject.sclerotherapy

Search Results

Now showing 1 - 3 of 3
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    TREATMENT OF LYMPHATIC MALFORMATIONS IN CHILDREN: 3 YEARS EXPERIENCE
    (University of Tetovo, 2023-05)
    ;
    Njomza LUMANI-BAKIJI
    ;
    Lazo JOVCHESKI
    ;
    Aleksandar STEPANOVSKI
    Introduction: Lymphatic malformations (LM) are congenital benign malformations from the group of slow-flow vascular anomalies consisting of pathological cystic dilatation of the lymphatic vessels. The incidence of LM ranges from 1.5 to 2.8% in 2000 to 4000 newborn children, and are relatively rare congenital vascular anomalies. They are characterized with equal representation between the genders. From the structural aspect, LM are divided into macrocystic, microcystic and mixed type, with its own therapeutic and prognostic implications. A small percentage of LM are combined with additional anomalies and are part of syndromes such as CLOVES, Klippel-Trenaunay, Proteus and others. In recent years, the method of choice in the treatments is sclerosing as a non-invasive method achieving almost excellent results.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    TREATMENT OF VENOUS MALFORMATIONS IN PEDIATRIC POPULATION – THREE- YEAR EXPERIENCE
    (Институт за јавно здравје на Република Македонија = Institute of public health of Republic of Macedonia, 2022-12-30)
    ;
    ;
    ;
    ;
    Lumani-Bakiji, Njomza
    Venous malformations (VMs) are a type of vascular malformations that result in abnormal development of veins that become extensible over time due to an error in vascular morphogenesis. They usually appear in newborns or in early adulthood as a bluish, soft, swollen and eventually painful skin formation. Treatment includes conservative therapy, sclerotherapy, and surgical excision. Aim of the paper is to evaluate the therapeutic effect of sclerotherapy in pediatric patients with venous malformations. Material and methods: In a three-year period, from 2019 to 2021, venous malformations were found in 33 patients aged 4 to 14 years (average age: 8 years). Pain as a symptom occurred in 8 patients. Two patients had lesions measuring up to 5 cm and 5 cm, respectively, while in the remaining subjects the lesion was over 5 cm. Ultrasound was performed routinely in all subjects, and MRI in two patients. Conservative treatment was instituted in 13 patients with venous malformations of the extremities; surgical excision with local reconstruction was performed in 11 patients, and sclerotherapy with bleomycin under general anesthesia was performed in 8 patients. Combined treatment was used in one patient that presented with venous malformation of the upper arm that underwent partial sclerotherapy with subsequent operative excision due to a phlebolith. Follow-up examinations revealed regression of the change not only from functional but from aesthetic aspect as well. Conclusion: Sclerotherapy is the established golden standard, first-line treatment for venous malformations. Excellent results were achieved as the reduction of the lesions was below 50% of the initial size. However, the modality of treatment should be individualized to each patient as it can sometimes require a combination of more than one treatment option. Venous malformations are best treated early, but they usually recur over time. Treatment helps relieve symptoms and control the growth of vascular malformations.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Ultrasound - Guided Percutaneous Sclerotherapy of Simple Renal Cysts - Five Years Report
    (Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs, 2020)
    ;
    ;
    ;
    ;
    Introduction. The sclerotherapy is considered a safe and effective treatment of simple renal cysts, usually per- formed by urologists. It was a five-year retrospective report on our tertiary clinical experience with simple renal cysts sclerotherapy performed by nephrologists. Methods. We analyzed the medical histories of patients who underwent sclerotherapy from January 2015 until the end of December 2019 counting overall 23 sessions of sclerotherapy. The method (aspiration or drainage) was chosen according to cyst size and depth. Sclerothe- rapy with 96% alcohol was performed. The cyst size was recorded, and the curative effect was evaluated by the residual cyst volume; over 20% residua in the cyst size was considered as a failed treatment. Patients we- re reexamined by ultrasound at 12-month follow-up, or earlier if symptomatic. Results. The mean age of patients was 58.68±11.08 years and majority of them were females. Most of the cysts [17] induced flank pain, dysregulated hypertension was present in 22% of patients and one have obstructted the urine flow. The mean cyst volume was 540±307.51 ml. All cysts were successfully treated. The mean cyst volume decreased significantly. Concerning the compli- cations, sporadic cases of pain and vomitus occurred du- ring only three treatment procedures. At the follow-up, all patients who suffered from unsatisfactory blood pre- ssure control improved and the hydronephrosis resolved. In five cases there was reoccurrence of a symptomatic cyst, with a need of re-treatment in the follow-up period. Conclusion. Ultrasound-guided aspiration and sclerothe- rapy of simple renal cysts is a safe and effective proce- dure that may be carried out by nephrologists.